Business Daily Media

Men's Weekly

.

Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

  • Written by PR Newswire
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

PARIS, March 23, 2021 /PRNewswire/ -- Unither Pharmaceuticals, the Blow-Fill-Seal (BFS) worldwide leader, provides diagnostic companies with capacity solutions and innovative technologies for their testing kits (Covid, Flu, etc.).

Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.) Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

With more than 10 million unit-doses manufactured each month for Covid testing kits, the French CDMO answers to current challenges based on its sterile unit doses development and manufacturing expertise.

The use of Blow-Fill-Seal technology, enables RNase-free single doses, that can also be sterile if necessary.

Through its 5 BFS plants on three continents (in France, the United States and China) and a R&D development center, Unither is able to manage the full development of a diluent or reagent from formulation to production.

About Unither Pharmaceuticals

Founded in Amiens, France, in 1993, Unither Pharmaceuticals has become a worldwide leader in drug manufacturing for generic pharmaceutical companies including but not limited to, eye drops and respiratory unit doses, saline solutions, and stick-packs.  

Unither Pharmaceuticals has 7 manufacturing sites and 1 R&D center located in France, the United States, China and Brazil. These sites generated a revenue of €330 million in 2020 with a headcount exceeding 1.600 employees.

Website : www.unither-pharma.com[1]

Blow-Fill-Seal : https://www.unither-pharma.com/technologies-innovations/blow-fill-seal-bfs/?lang=en[2]

Article : https://www.unither-pharma.com/news/diluent-or-immuno-reagent-solutions-for-your-diagnostic-testing-kits-covid-flu-etc/?lang=en[3]

Contact: testing@unither-pharma.com[4]  

Photo - https://mma.prnasia.com/media2/1471718/diluent_or_immuno_reagent_solutions.jpg?p=medium600[5] Logo - https://mma.prnasia.com/media2/1471719/Unither_Pharmaceuticals_Logo.jpg?p=medium600[6]

Read more https://www.prnasia.com/story/archive/3317776_AE17776_0

Work-life Balance Key to Solving Construction Talent Shortage

New data from leading talent company Randstad Australia shows flexible working and work-life balance could be critical to addressing ongoing talen...

How to Apply for More Jobs in Less Time Using AI Automation

Most job seekers spend 11 to 14 hours per week on applications and still hear nothing back. That's not a motivation problem. That's a process proble...

Why Middle Australia Is Quietly Driving the Shift Away From Car Ownership

The narrative around changing attitudes to car ownership has long focused on Gen Z. Younger Australians are often portrayed as the generation movi...

Launchd Acquires WeAreTENZING as ANZ Creator Economy Spend Nears $1 Billion

Launchd, Australia's leading talent-first creator economy group, has acquired WeAreTENZING, one of New Zealand's most respected talent agencies, b...

Time to punch above our weight and stop shadowboxing on AI

Australia prides itself on being an innovation economy. We celebrate startups, talk about productivity, and lean into our reputation for punching ...

Colter Bay Capital Launches as Australia’s Newest Institutional Private Credit Fund

Led by seasoned capital markets veteran Mark Wang, the fund is purpose-built to serve Australia’s most productive yet chronically underserved busi...